Background Inflammation is causally related to atherothrombosis. Treatment with canakinumab,
a monoclonal antibody that inhibits inflammation by neutralizing interleukin-1β, resulted …

Many developments have occurred since the publication of the widely-used 2009 Canadian
Cardiovascular Society (CCS) Dyslipidemia guidelines. Here, we present an updated …

… Jacques Genest MD1, Ruth McPherson MD PhD2, Jiri Frohlich MD3, Todd Anderson
MD4, Norm Campbell MD4, André Carpentier MD5, Patrick Couture MD6, Robert Dufour …

Since the publication of the 2012 guidelines new literature has emerged to inform decision-making.
The 2016 guidelines primary panel selected a number of clinically relevant …

Hypertension Canada provides annually updated, evidence-based guidelines for the diagnosis,
assessment, prevention, and treatment of hypertension in adults and children. This year, …

Hypertension Canada's Canadian Hypertension Education Program Guidelines Task Force
provides annually updated, evidence-based recommendations to guide the diagnosis, …

Hypertension Canada provides annually updated, evidence-based guidelines for the diagnosis,
assessment, prevention, and treatment of hypertension. This year, we introduce 10 new …

Hypertension Canada’s 2020 guidelines for the prevention, diagnosis, risk assessment, and
treatment of hypertension in adults and children provide comprehensive, evidence-based …

The 2021 guidelines primary panel selected clinically relevant questions and produced
updated recommendations, on the basis of important new findings that have emerged since the …

Background Inflammation plays a fundamental role in atherothrombosis. Yet, whether direct
inhibition of inflammation will reduce the occurrence of adverse cardiovascular outcomes is …